Trademark: 87817842
Word
KNACK PHARMACEUTICALS YOUR HEALTH PARTNER
Status Date
Thursday, November 3, 2022
Filing Date
Friday, March 2, 2018
Published for Opposition
Tuesday, July 24, 2018
Abandoned Date
Monday, October 24, 2022
5 Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of epilepsy disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of skin diseases, allergies and rheumatic disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of Alzheimer; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of ophthalmic related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of musculoskeletal related diseases and disorders; Pharmaceutical preparations for the support and promotion of bone strength and health; Pharmaceutical preparations for the treatment of bone disorders and bone diseases; Pharmaceutical preparations for the treatment of toxic effects; Pharmaceutical preparations for use as injectable anesthetics; Pharmaceutical preparations for use as contraceptives; Pharmaceutical preparations for fertility enhancement purposes; Pharmaceutical preparations for use in hormone replacement therapy; Pharmaceutical preparations for the prevention and treatment of hormone disorders and deficiencies; Pharmaceutical preparations for inducing labor and facilitating nursing; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the treatment and prevention of metabolic, endocrine and kidney related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of nausea and vomiting; Pharmaceutical preparations for the prevention and treatment of aids-related disorders and diseases; Pharmaceutical preparations for treatment and prevention of viral and bacterial infections; Pharmaceutical preparations, namely, injectable contraceptives
"PHARMACEUTICALS" AND "HEALTH"
Nov 4, 2022
Abandonment Notice E-Mailed - Failure To Respond
Nov 3, 2022
Abandonment Notice Mailed - Failure To Respond
Nov 3, 2022
Abandonment - Failure To Respond Or Late Response
Apr 21, 2022
Notification Of Final Refusal Emailed
Apr 21, 2022
Final Refusal E-Mailed
Apr 21, 2022
Su - Final Refusal - Written
Mar 28, 2022
Assigned To Examiner
Mar 23, 2022
Teas/Email Correspondence Entered
Mar 23, 2022
Correspondence Received In Law Office
Mar 16, 2022
Teas Response To Office Action Received
Nov 17, 2021
Teas Change Of Correspondence Received
Nov 17, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Nov 17, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 17, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 17, 2021
Notification Of Non-Final Action E-Mailed
Sep 17, 2021
Non-Final Action E-Mailed
Sep 17, 2021
Su - Non-Final Action - Written
Sep 17, 2021
Statement Of Use Processing Complete
Sep 10, 2021
Use Amendment Filed
Sep 10, 2021
Teas Statement Of Use Received
Mar 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 16, 2021
Sou Extension 5 Granted
Mar 2, 2021
Sou Extension 5 Filed
Mar 16, 2021
Case Assigned To Intent To Use Paralegal
Mar 2, 2021
Sou Teas Extension Received
Aug 8, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 6, 2020
Sou Extension 4 Granted
Aug 6, 2020
Sou Extension 4 Filed
Aug 6, 2020
Sou Teas Extension Received
Mar 7, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 5, 2020
Sou Extension 3 Granted
Mar 5, 2020
Sou Extension 3 Filed
Mar 5, 2020
Sou Teas Extension Received
Aug 30, 2019
Notice Of Approval Of Extension Request E-Mailed
Aug 28, 2019
Sou Extension 2 Granted
Aug 28, 2019
Sou Extension 2 Filed
Aug 28, 2019
Sou Teas Extension Received
Mar 6, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 4, 2019
Sou Extension 1 Granted
Mar 4, 2019
Sou Extension 1 Filed
Mar 4, 2019
Sou Teas Extension Received
Sep 18, 2018
Noa E-Mailed - Sou Required From Applicant
Jul 24, 2018
Official Gazette Publication Confirmation E-Mailed
Jul 24, 2018
Published For Opposition
Jul 4, 2018
Notification Of Notice Of Publication E-Mailed
Jun 15, 2018
Approved For Pub - Principal Register
Jun 15, 2018
Examiner's Amendment Entered
Jun 15, 2018
Assigned To Lie
Jun 14, 2018
Notification Of Examiners Amendment E-Mailed
Jun 14, 2018
Examiners Amendment E-Mailed
Jun 14, 2018
Examiners Amendment -Written
Jun 13, 2018
Assigned To Examiner
Mar 9, 2018
New Application Office Supplied Data Entered
Mar 6, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
